Evidence map›Paper›PMID 25634934›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2015

Assessing Constituent Levels in Smokeless Tobacco Products: A New Approach to Engaging and Educating the Public.

Eugene Borgida, Barbara Loken, Allison L Williams, Joseph Vitriol, Irina Stepanov, Dorothy Hatsukami

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Mapping of Crowdsourcing in Health: Systematic Review.Journal of medical Internet research · 2018
    Pooled it
  2. Pooled it
  3. Trial
  4. Can the Public Be Educated About Constituents in Smokeless Tobacco? A Three-Wave Randomized Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  5. Article
  6. Article
  7. The Effect of Tobacco Control Policies on US Smokeless Tobacco Use: A Structured Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017
    Review
  8. A Proposed Collaboration Against Big Tobacco: Common Ground Between the Vaping and Public Health Community in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eugene BorgidaDepartment of Psychology, University of Minnesota-Twin Cities, Minneapolis, MN; borgi001@umn.edu.
Barbara LokenDepartment of Marketing, Carlson School of Management, University of Minnesota-Twin Cities, Minneapolis, MN;
Allison L WilliamsDepartment of Psychology, University of Minnesota-Twin Cities, Minneapolis, MN;
Joseph VitriolDepartment of Psychology, University of Minnesota-Twin Cities, Minneapolis, MN;
Irina StepanovDivision of Environmental Health Sciences, University of Minnesota-Twin Cities, Minneapolis, MN;
Dorothy HatsukamiDepartment of Psychiatry, School of Medicine, University of Minnesota-Twin Cities, Minneapolis, MN.
Twin Cities Orthopedics · USUniversity of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
Novel Determinants and Measures of Smokeless Tobacco UseR01CA141531 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K · 2009 to 2014
$2.8M
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA141531NCI NIH HHS R01CA141531
6 · The paper itself

Abstract

introductionProviding accurate information about the constituents in nicotine-containing products may help tobacco users make informed decisions about product choices. An experimental study examined a novel approach for presenting accurate constituent information about brands and types of smokeless tobacco (SLT) that could be understood by the general public.

methodsParticipants were recruited through Amazon's Mechanical Turk and presented information online about 2 constituent dimensions of SLT products-nicotine and/or toxicity (for simplicity, "toxicity" in this study refers to carcinogenic constituents) Participants completed measures of knowledge and tobacco health risks at 2 time points: before and after exposure to constituent information.

resultsParticipants were found to increase their knowledge that toxicity contributes to disease risk and nicotine contributes to addiction, that SLT products vary in their levels of nicotine and toxicity, and that both SLT and cigarette products have higher toxicity than medicinal nicotine replacement therapies (e.g., nicotine lozenges). Study results showed no differences when presenting toxicity information alone versus presenting it in conjunction with nicotine information, and found no misperceptions or confusions about the relative harmfulness of cigarettes, SLT, or nicotine replacement therapy.

conclusionsProviding tobacco constituent information to smokers and nonsmokers will improve their knowledge about the relative toxicity across products and variations within a class of tobacco products without compromising the health risks associated with tobacco use.

Indexed as

Health EducationProduct LabelingAdultCarcinogensFemaleHumansMaleRisk-TakingSmoking CessationSurveys and QuestionnairesTobacco, SmokelessUnited StatesCarcinogens

Identifiers

PMID25634934
PMCPMC4612344
OpenAlexW1972471539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.